15 Penny Stocks Poised To Explode According To Hedge Funds

Page 9 of 16

8. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

During the second quarter, the number of funds from our database long Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) inched down by one to 18 funds, which held $180.85 million worth of stock, or 28.80% of the outstanding shares. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is engaged in the development of small molecule drug therapies for immune system disorders and infectious diseases. The company has recently reported positive results from a Phase 2 study in a drug for the treatment of paroxysmal nocturnal hemoglobinuria, a rare blood disorder.

Page 9 of 16